Brought to you by 
J&J acquires TransForm Pharmaceuticals for $230mm in cash
29 Aug 2006
Executive Summary
Just a week after announcing it would buy Closure Medical for $370mm, Johnson & Johnson has now agreed to acquire TransForm Pharmaceuticals (develops crystalline forms of drug molecules) for $230mm in cash.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- ADMET
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
J&J acquires TransForm Pharmaceuticals for $230mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice